Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs02514413

Ligand	Ligand name	Chain	PDB	Tanimoto
DAH	3,4-DIHYDROXYPHENYLALANINE	A,B	1RNR	0.73
DAH	3,4-DIHYDROXYPHENYLALANINE	A	6PAH	0.73
DAH	3,4-DIHYDROXYPHENYLALANINE	A,B	1IVV	0.73
GPS	(9S,10S)-9-(S-GLUTATHIONYL)-10-HYDROXY-9,10-DIHYDROPHENANTHRENE	A,B	2GST	0.73
GPS	(9S,10S)-9-(S-GLUTATHIONYL)-10-HYDROXY-9,10-DIHYDROPHENANTHRENE	A,B	6GSW	0.73
GPS	(9S,10S)-9-(S-GLUTATHIONYL)-10-HYDROXY-9,10-DIHYDROPHENANTHRENE	A,B	6GSV	0.73
GPS	(9S,10S)-9-(S-GLUTATHIONYL)-10-HYDROXY-9,10-DIHYDROPHENANTHRENE	A	1B4P	0.73
GPS	(9S,10S)-9-(S-GLUTATHIONYL)-10-HYDROXY-9,10-DIHYDROPHENANTHRENE	A,B	6GSX	0.73
GPS	(9S,10S)-9-(S-GLUTATHIONYL)-10-HYDROXY-9,10-DIHYDROPHENANTHRENE	A,B	6GSU	0.73
545	[2-AMINO-3-(4-HYDROXY-PHENYL)-PROPIONYLAMINO]-(1,3,4,5-TETRAHYDROXY-4-HYDROXYMETHYL-PIPERIDIN-2-YL)- ACETIC ACID BUTYL ESTER	A	1JIK	0.72
DYS	S-[5-(2-aminoethyl)-2,3-dihydroxyphenyl]-L-cysteine	B	2R1T	0.82
IYG	N-ALPHA-ACETYL-3,5-DIIODOTYROSYLGLYCINE	A	1OPM	0.74
485	[2-AMINO-3-(4-HYDROXY-PHENYL)-PROPIONYLAMINO]- (3,4,5-TRIHYDROXY-6-METHYL-TETRAHYDRO-PYRAN-2-YL)- ACETIC ACID	A	1JIL	0.72
IBG	GAMMA-GLUTAMYL[S-(2-IODOBENZYL)CYSTEINYL]GLYCINE	A	1M9B	0.71
CRV	N-[1-(AMINOMETHYL)CYCLOPROPYL]-3-(BENZYLSULFONYL)-N~2~-[(1S)-2,2,2-TRIFLUORO-1-(4-HYDROXYPHENYL)ETHYL]-L-ALANINAMIDE	A,B	2FRA	0.7
GSO	L-GAMMA-GLUTAMYL-S-[(2S)-2-HYDROXY-2-PHENYLETHYL]-L-CYSTEINYLGLYCINE	A,B,C,D	2C4J	0.77
CSY	[4-(4-HYDROXY-BENZYL)-2-(2-HYDROXY-1-METHYL-ETHYL)-5-OXO-IMIDAZOLIDIN-1-YL]-ACETIC ACID	A,B	2AH8	0.71
CSY	[4-(4-HYDROXY-BENZYL)-2-(2-HYDROXY-1-METHYL-ETHYL)-5-OXO-IMIDAZOLIDIN-1-YL]-ACETIC ACID	A,B,C,D	1HCJ	0.71
CSY	[4-(4-HYDROXY-BENZYL)-2-(2-HYDROXY-1-METHYL-ETHYL)-5-OXO-IMIDAZOLIDIN-1-YL]-ACETIC ACID	A,B,C,D	1W7S	0.71
CSY	[4-(4-HYDROXY-BENZYL)-2-(2-HYDROXY-1-METHYL-ETHYL)-5-OXO-IMIDAZOLIDIN-1-YL]-ACETIC ACID	A,B,C,D	1W7T	0.71
CSY	[4-(4-HYDROXY-BENZYL)-2-(2-HYDROXY-1-METHYL-ETHYL)-5-OXO-IMIDAZOLIDIN-1-YL]-ACETIC ACID	A,B	2AHA	0.71
CSY	[4-(4-HYDROXY-BENZYL)-2-(2-HYDROXY-1-METHYL-ETHYL)-5-OXO-IMIDAZOLIDIN-1-YL]-ACETIC ACID	A	1EME	0.71
CSY	[4-(4-HYDROXY-BENZYL)-2-(2-HYDROXY-1-METHYL-ETHYL)-5-OXO-IMIDAZOLIDIN-1-YL]-ACETIC ACID	A,B	1KP5	0.71
CSY	[4-(4-HYDROXY-BENZYL)-2-(2-HYDROXY-1-METHYL-ETHYL)-5-OXO-IMIDAZOLIDIN-1-YL]-ACETIC ACID	A	1EMM	0.71
CSY	[4-(4-HYDROXY-BENZYL)-2-(2-HYDROXY-1-METHYL-ETHYL)-5-OXO-IMIDAZOLIDIN-1-YL]-ACETIC ACID	A	1EML	0.71
CSY	[4-(4-HYDROXY-BENZYL)-2-(2-HYDROXY-1-METHYL-ETHYL)-5-OXO-IMIDAZOLIDIN-1-YL]-ACETIC ACID	A,B,C,D	1W7U	0.71
CSY	[4-(4-HYDROXY-BENZYL)-2-(2-HYDROXY-1-METHYL-ETHYL)-5-OXO-IMIDAZOLIDIN-1-YL]-ACETIC ACID	A,B,C,D	1EMC	0.71
CSY	[4-(4-HYDROXY-BENZYL)-2-(2-HYDROXY-1-METHYL-ETHYL)-5-OXO-IMIDAZOLIDIN-1-YL]-ACETIC ACID	A	2HPW	0.71
TI2	(2-SULFANYL-3-PHENYLPROPANOYL)-PHE-TYR	A	1QF0	0.77
GBI	S-(3-IODOBENZYL)GLUTATHIONE	A	2GSQ	0.71
629	[2-AMINO-3-(4-HYDROXY-PHENYL)-PROPIONYLAMINO]-(1,3,4,5-TETRAHYDROXY-4-HYDROXYMETHYL-PIPERIDIN-2-YL)- ACETIC ACID	A	1JIJ	0.74
CJO	[(2R,4R)-2-[(1R,2R)-1-amino-2-hydroxypropyl]-4-(4-hydroxybenzyl)-5-oxoimidazolidin-1-yl]acetic acid	A	2QT2	0.7
ARY	ARYLOMYCIN A2	A,B	1T7D	0.7
ABY	N-(4-AMINOBUTANOYL)-S-(4-METHOXYBENZYL)-L-CYSTEINYLGLYCINE	A,B	1PL2	0.73
ABY	N-(4-AMINOBUTANOYL)-S-(4-METHOXYBENZYL)-L-CYSTEINYLGLYCINE	A,B	1PL1	0.73
YBY	N-{[(1S)-1-carboxy-2-(4-hydroxy-3-iodophenyl)ethyl]carbamoyl}-L-glutamic acid	A	3D7F	0.73
CCY	2-(1-AMINO-2-MERCAPTO-ETHYL)-5-(4-HYDROXY-BENZYL)-3-(ETHANOYL)-3,5-DIHYDRO-IMIDAZOL-4-ONE	A	1EMK	0.75
0E4	N-acetyl-L-tyrosyl-L-valyl-L-alanyl-L-aspartic acid	B,D	3GJS	0.76
AXL	2-{1-[2-AMINO-2-(4-HYDROXY-PHENYL)-ACETYLAMINO]-2-OXO-ETHYL}-5,5-DIMETHYL-THIAZOLIDINE-4-CARBOXYLIC ACID	B	1LL9	0.78
GSB	S-BENZYL-GLUTATHIONE	A,B,C,D	1FRO	0.72
GSB	S-BENZYL-GLUTATHIONE	A,B,C,D	1GUH	0.72
OPT	S-benzyl-N-(biphenyl-4-ylacetyl)-L-cysteinyl-N~5~-(diaminomethyl)-D-ornithyl-N-(2-phenylethyl)-L-tyrosinamide	A,B	3BC3	0.72
383	[2-AMINO-3-(4-HYDROXY-PHENYL)-PROPIONYLAMINO]- (2,4,5,8-TETRAHYDROXY-7-OXA-2-AZA-BICYCLO[3.2.1]OCT-3-YL)- ACETIC ACID	A	1JII	0.71
1C5	[[O-PHOSPHONO-N-ACETYL-TYROSINYL]-GLUTAMYL-3[CYCLOHEXYLMETHYL]ALANINYL]-AMINE	A	1BKM	0.74
YTT	(3S,6S)-3,6-bis(4-hydroxybenzyl)piperazine-2,5-dione	A	3G5H	0.72
CFY	[(2S)-2-{(2R)-2-[(1S)-1-amino-2-phenylethyl]-2-hydroxy-2,5-dihydro-1,3-thiazol-4-yl}-4-(4-hydroxybenzyl)-5-oxo-2,5-dihydro-1H-imidazol-1-yl]acetic acid	A,B,C,D	2ZMW	0.73
CFY	[(2S)-2-{(2R)-2-[(1S)-1-amino-2-phenylethyl]-2-hydroxy-2,5-dihydro-1,3-thiazol-4-yl}-4-(4-hydroxybenzyl)-5-oxo-2,5-dihydro-1H-imidazol-1-yl]acetic acid	A	2ZMU	0.73
IYT	N-ALPHA-ACETYL-3,5-DIIODOTYROSYL-D-THREONINE	A	1SDW	0.71
SD2	N-(SULFANYLACETYL)TYROSYLPROLYLMETHIONINAMIDE	A,B	1PWQ	0.77
DRS	(9S,12S)-9-(1-methylethyl)-7,10-dioxo-2-oxa-8,11-diazabicyclo[12.2.2]octadeca-1(16),14,17-triene-12-carboxylic acid	A,B	3BXS	0.71
EDE	EDEINE B	A,B,D,E,G,H,J,K,L,N,P,Q,R,T	1I95	0.71
YVN	N-({(1R,2R,3S)-2-(methylcarbamoyl)-3-[4-(phosphonooxy)phenyl]cyclopropyl}carbonyl)-L-valyl-L-aspartamide	A,B	2HUW	0.7
TY3	3-HYDROXY-L-TYROSINE	A,B	2VH3	0.73
CEH	5-{3-(S)-(4-(R)-ACETYLAMINO-4-CARBOXY-BUTYRYLAMINO)-3-[1-(R)-(1-(R)-CARBOXY-ETHYLCARBAMOYL)-ETHYLCARBAMOYL]-PROPYL}-2-(CARBOXY-PHENYLACETYLAMINO-METHYL)-3,6-DIHYDRO-2H-[1,3]THIAZINE-4-CARBOXYLIC ACID	A	1HVB	0.73
GPR	(9R,10R)-9-(S-GLUTATHIONYL)-10-HYDROXY-9,10-DIHYDROPHENANTHRENE	A,B	1MTC	0.73
GPR	(9R,10R)-9-(S-GLUTATHIONYL)-10-HYDROXY-9,10-DIHYDROPHENANTHRENE	A,B	5FWG	0.73
GPR	(9R,10R)-9-(S-GLUTATHIONYL)-10-HYDROXY-9,10-DIHYDROPHENANTHRENE	A,B	2PGT	0.73
GPR	(9R,10R)-9-(S-GLUTATHIONYL)-10-HYDROXY-9,10-DIHYDROPHENANTHRENE	A,B	3FYG	0.73
GPR	(9R,10R)-9-(S-GLUTATHIONYL)-10-HYDROXY-9,10-DIHYDROPHENANTHRENE	A,B	3GST	0.73
NYS	S-{5-[(1R)-2-amino-1-hydroxyethyl]-2,3-dihydroxyphenyl}-L-cysteine	B	2R1V	0.79
NLT	N-DODECANOYL-L-TYROSINE	A,B,C,D,E,F,G,H	2G0B	0.75